IMUX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.00%

Insider Buying (Last 12 Months): $100,395.00

Insider Selling (Last 12 Months): $0.00

Immunic Insider Trading History Chart

Immunic Share Price & Price History

^$1.12

▼ -0.049 (-4.19%)

As of 11/14/2024 11:17 AM ET

Days: 30 | 90 | 365

Central Bank Abandons USD

From True Gold Republic | Ad

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

Immunic Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Richard Alan Rudick	Director	Buy	87,300	$1.15	$100,395.00	87,300
5/15/2023	Glenn Whaley	CFO	Buy	5,000	$1.75	$8,750.00	25,510
11/23/2022	Joerg Neermann	Director	Buy	18,000	$1.39	$25,020.00	18,000
11/22/2022	Daniel Vitt	CEO	Buy	8,000	$1.35	$10,800.00	376,877
11/7/2022	Glenn Whaley	CFO	Buy	5,000	$1.50	$7,500.00	20,510
6/3/2022	Daniel Vitt	CEO	Buy	5,000	$3.10	$15,500.00	368,877
6/3/2022	Glenn Whaley	CFO	Buy	3,500	$3.04	$10,640.00	12,568
5/12/2022	Andreas Muehler	Insider	Buy	3,500	$5.10	$17,850.00	297,986
5/12/2022	Andreas Muehler	Insider	Buy	3,500	$5.10	$17,850.00	297,986
5/12/2022	Duane Nash	Chairman	Buy	10,000	$5.03	$50,300.00	22,032
5/12/2022	Glenn Whaley	CFO	Buy	3,000	$5.08	$15,240.00	9,068

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

SEC Filings (Institutional Ownership Changes) for Immunic (NASDAQ:IMUX)

51.82% of Immunic stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunic Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	102,257	$0.17M	0.0%	+70.8%	0.114%
11/5/2024	GSA Capital Partners LLP	32,766	$54K	0.0%	-71.9%	0.036%
8/14/2024	Marshall Wace LLP	39,621	$44K	0.0%	-20.0%	0.044%
8/9/2024	Renaissance Technologies LLC	291,087	$0.32M	0.0%	-61.0%	0.323%
5/20/2024	Virtu Financial LLC	19,088	$25K	0.0%	N/A	0.021%
5/17/2024	Ikarian Capital LLC	1,612,378	$2.13M	0.2%	+258.3%	1.790%
5/16/2024	Janus Henderson Group PLC	6,993,007	$9.27M	0.0%	N/A	7.763%
5/16/2024	BVF Inc. IL	8,902,972	$11.75M	0.3%	N/A	9.884%
5/10/2024	Acadian Asset Management LLC	239,962	$0.32M	0.0%	-57.1%	0.266%
5/10/2024	Vanguard Group Inc.	3,394,047	$4.48M	0.0%	+100.7%	3.768%
4/23/2024	Summit Trail Advisors LLC	18,600	$25K	0.0%	N/A	0.021%
2/22/2024	Sierra Summit Advisors LLC	324,829	$0.49M	0.1%	N/A	0.719%
2/7/2024	Gratus Capital LLC	1,941,454	$2.91M	0.2%	+15.1%	4.300%
1/12/2024	Sweet Financial Partners LLC	29,829	$45K	0.0%	N/A	0.066%
11/15/2023	RTW Investments LP	4,335,255	$6.37M	0.1%	+0.9%	9.720%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	24,773	$36K	0.0%	-77.0%	0.056%
11/13/2023	Acadian Asset Management LLC	757,250	$1.11M	0.0%	+26.8%	1.698%
11/9/2023	Cowen AND Company LLC	317,059	$0.47M	0.0%	-11.4%	0.711%
11/9/2023	Innovis Asset Management LLC	272,457	$0.40M	0.2%	+46.3%	0.611%
8/14/2023	Deep Track Capital LP	308,314	$0.77M	0.0%	-87.8%	0.691%
8/8/2023	Balboa Wealth Partners	12,000	$30K	0.0%	N/A	0.027%
8/7/2023	Acadian Asset Management LLC	597,277	$1.50M	0.0%	+439.2%	1.339%
8/3/2023	Innovis Asset Management LLC	186,240	$0.47M	0.2%	+130.6%	0.419%
8/3/2023	Gratus Capital LLC	1,678,793	$4.21M	0.3%	+1.4%	3.781%
7/27/2023	Virtu Financial LLC	67,424	$0.17M	0.0%	N/A	0.152%
7/24/2023	Vontobel Holding Ltd.	10,000	$25K	0.0%	N/A	0.023%
5/15/2023	Logos Global Management LP	421,184	$0.63M	0.1%	N/A	0.949%
5/15/2023	RTW Investments LP	4,294,459	$6.40M	0.1%	+11.2%	9.671%
5/10/2023	Innovis Asset Management LLC	80,773	$0.12M	0.0%	N/A	0.182%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	86,907	$0.13M	0.0%	N/A	0.196%
5/9/2023	Cowen AND Company LLC	357,855	$0.53M	0.1%	-54.8%	0.806%
4/20/2023	Gratus Capital LLC	1,655,405	$2.47M	0.2%	-0.8%	3.728%
2/14/2023	RA Capital Management L.P.	632,184	$0.89M	0.0%	N/A	1.425%
2/13/2023	Vivo Capital LLC	632,184	$0.83M	0.1%	N/A	1.425%
2/13/2023	Artal Group S.A.	1,274,713	$1.79M	0.1%	+82.1%	2.874%
2/9/2023	Cowen AND Company LLC	791,024	$1.11M	0.1%	-34.1%	1.783%
1/27/2023	Gratus Capital LLC	1,668,294	$2.34M	0.2%	+121.5%	3.761%
11/15/2022	Parkman Healthcare Partners LLC	657,643	$2.08M	0.6%	+1.2%	1.675%
11/14/2022	Lynx1 Capital Management LP	1,072,288	$3.39M	3.1%	-2.9%	2.731%
11/14/2022	Verition Fund Management LLC	698,934	$2.21M	0.0%	+14.6%	1.780%
11/14/2022	Ergoteles LLC	24,725	$78K	0.0%	-72.6%	0.063%
11/14/2022	UBS Oconnor LLC	197,988	$0.63M	0.0%	-14.9%	0.504%
11/4/2022	Gratus Capital LLC	753,190	$2.38M	0.3%	N/A	2.464%
10/25/2022	Denali Advisors LLC	17,000	$54K	0.0%	N/A	0.056%
8/30/2022	Verition Fund Management LLC	609,765	$2.12M	0.0%	+331.5%	1.995%
8/16/2022	Corton Capital Inc.	12,142	$42K	0.0%	N/A	0.040%
8/16/2022	Delphia USA Inc.	13,181	$46K	0.0%	N/A	0.043%
8/15/2022	Point72 Asset Management L.P.	1,325,000	$4.60M	0.0%	+82.8%	4.335%
8/5/2022	Cowen AND Company LLC	1,200,691	$4.17M	0.4%	-6.3%	3.932%
6/2/2022	Verition Fund Management LLC	141,319	$1.60M	0.0%	-26.2%	0.463%
5/17/2022	RTW Investments LP	2,705,513	$30.57M	0.6%	+57.7%	8.859%
5/17/2022	Endurant Capital Management LP	130,567	$1.48M	0.4%	-29.2%	0.428%
5/13/2022	Parkman Healthcare Partners LLC	1,089,251	$12.31M	3.6%	+11.8%	3.567%
5/13/2022	DLD Asset Management LP	50,000	$0.57M	0.0%	N/A	0.164%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,031	$34K	0.0%	N/A	0.011%
4/18/2022	Golden Green Inc.	32,649	$0.37M	0.3%	-49.7%	0.117%
2/16/2022	Ghost Tree Capital LLC	165,000	$1.58M	0.6%	-37.7%	0.629%
2/14/2022	Altium Capital Management LP	317,000	$3.03M	0.8%	+890.0%	1.208%
2/14/2022	Point72 Asset Management L.P.	725,000	$6.94M	0.0%	+16.0%	2.762%
2/14/2022	Soleus Capital Management L.P.	175,000	$1.68M	0.2%	N/A	0.667%
2/11/2022	KCK LTD.	69,704	$0.67M	0.5%	N/A	0.266%
2/9/2022	Alps Advisors Inc.	30,370	$0.29M	0.0%	-5.6%	0.116%
2/4/2022	Otter Creek Advisors LLC	120,000	$1.15M	0.7%	+20.0%	0.457%
1/21/2022	Golden Green Inc.	64,910	$0.62M	0.5%	-25.5%	0.247%
11/17/2021	Altium Capital Management LP	32,021	$0.32M	0.1%	N/A	0.122%
11/16/2021	Schonfeld Strategic Advisors LLC	54,400	$0.48M	0.0%	+6.9%	0.207%
11/16/2021	Two Sigma Advisers LP	165,218	$1.46M	0.0%	+1.8%	0.629%
11/16/2021	Two Sigma Investments LP	140,067	$1.24M	0.0%	-9.1%	0.534%
11/16/2021	Millennium Management LLC	495,171	$4.38M	0.0%	+106.7%	1.886%
11/15/2021	Point72 Asset Management L.P.	625,000	$5.53M	0.0%	N/A	2.381%
11/15/2021	RTW Investments LP	1,370,814	$12.13M	0.2%	+48.9%	5.222%
11/15/2021	Sphera Funds Management LTD.	389,812	$3.45M	0.3%	N/A	1.485%
11/15/2021	First Manhattan Co.	250,000	$2.21M	0.0%	N/A	0.952%
11/12/2021	Parkman Healthcare Partners LLC	924,087	$8.18M	2.1%	+123.2%	3.520%
11/12/2021	Stonepine Capital Management LLC	22,409	$0.20M	0.1%	N/A	0.085%
11/12/2021	Geode Capital Management LLC	313,953	$2.78M	0.0%	+21.4%	1.196%
11/10/2021	Goldman Sachs Group Inc.	167,877	$1.49M	0.0%	+1,283.9%	0.640%
11/10/2021	Citigroup Inc.	3,981	$35K	0.0%	+93.6%	0.015%
11/10/2021	Otter Creek Advisors LLC	100,000	$0.89M	0.5%	+100.0%	0.381%
11/10/2021	Skandinaviska Enskilda Banken AB publ	36,162	$0.32M	0.0%	-20.9%	0.138%
11/9/2021	Barclays PLC	7,653	$68K	0.0%	+285.7%	0.029%
11/9/2021	BlackRock Inc.	1,251,145	$11.07M	0.0%	+11.1%	4.766%
11/4/2021	Deutsche Bank AG	10,768	$95K	0.0%	+16.9%	0.041%
11/2/2021	New York State Common Retirement Fund	10,045	$89K	0.0%	-24.7%	0.038%
11/1/2021	SG Americas Securities LLC	14,409	$0.13M	0.0%	N/A	0.055%
10/8/2021	Golden Green Inc.	87,085	$0.77M	0.6%	+2.3%	0.332%
8/27/2021	Endurant Capital Management LP	177,148	$2.17M	0.6%	+34.4%	0.675%
8/17/2021	Millennium Management LLC	239,556	$2.94M	0.0%	+50.4%	0.913%
8/16/2021	California State Teachers Retirement System	21,443	$0.26M	0.0%	+154.5%	0.082%
8/16/2021	Schonfeld Strategic Advisors LLC	50,900	$0.62M	0.0%	+20.9%	0.194%
8/16/2021	Charles Schwab Investment Management Inc.	39,458	$0.48M	0.0%	+117.7%	0.150%
8/16/2021	State Street Corp	351,296	$4.31M	0.0%	+41.1%	1.338%
8/16/2021	Nuveen Asset Management LLC	74,924	$0.92M	0.0%	+79.0%	0.285%
8/16/2021	Goldman Sachs Group Inc.	12,131	$0.15M	0.0%	N/A	0.046%
8/13/2021	Northern Trust Corp	165,289	$2.03M	0.0%	+64.9%	0.630%
8/13/2021	Geode Capital Management LLC	258,569	$3.17M	0.0%	+57.3%	0.985%
8/13/2021	Vanguard Group Inc.	711,773	$8.73M	0.0%	-2.7%	2.712%
8/13/2021	FMR LLC	1,192,722	$14.62M	0.0%	+0.6%	4.544%
8/12/2021	Trexquant Investment LP	10,674	$0.13M	0.0%	N/A	0.041%
8/12/2021	JPMorgan Chase & Co.	8,509	$0.10M	0.0%	+305.2%	0.032%

Data available starting January 2016

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Today's Range

Now: $1.12

$1.12

$1.18

50 Day Range

MA: $1.45

$1.15

$1.95

52 Week Range

Now: $1.12

$0.97

$2.11

Volume

117,951 shs

Average Volume

615,314 shs

Market Capitalization

$100.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of Immunic?: Immunic's top insider shareholders include:
Daniel Vitt (CEO)
Richard Alan Rudick (Director)
Glenn Whaley (CFO)
Joerg Neermann (Director)
Learn More about top insider investors at Immunic.
Who are the major institutional investors of Immunic?: Immunic's top institutional shareholders include:
Connor Clark & Lunn Investment Management Ltd. — 0.11%
GSA Capital Partners LLP — 0.04%
Learn More about top institutional investors of Immunic stock.
Which institutional investors are selling Immunic stock?: During the last quarter, IMUX stock was sold by these institutional investors:
GSA Capital Partners LLP
Which institutional investors are buying Immunic stock?: During the previous quarter, IMUX stock was purchased by institutional investors including:
Connor Clark & Lunn Investment Management Ltd.
In the last year, these company insiders have bought Immunic stock:
Daniel Vitt (CEO)
Richard Alan Rudick (Director)
Glenn Whaley (CFO)
Joerg Neermann (Director)
Learn More investors buying Immunic stock.